Provided by Tiger Fintech (Singapore) Pte. Ltd.

INCANNEX HEALTHCARE LTD

0.3770
-0.0265-6.57%
Post-market: 0.38110.0041+1.09%19:59 EDT
Volume:27.87M
Turnover:10.58M
Market Cap:131.20M
PE:-0.28
High:0.3980
Open:0.3731
Low:0.3643
Close:0.4035
52wk High:3.12
52wk Low:0.0800
Shares:348.00M
Float Shares:89.88M
Volume Ratio:0.77
T/O Rate:31.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3608
EPS(LYR):-1.3608
ROE:-381.09%
ROA:-73.46%
PB:9.80
PE(LYR):-0.28

Loading ...

Incannex Healthcare Announces Promising Phase 2 Results for IHL-42X, Highlighting Significant Improvements in Sleep and Cognitive Function for OSA Patients

Reuters
·
Aug 08

BRIEF-Incannex Healthcare Confirms Strong Cash Position No Plans Or Requirement To Fully Utilise ATM In Near Term

Reuters
·
Jul 31

Incannex Confirms Strong Cash Position; No Plans or Requirement to Fully Utilise Atm in Near Term

THOMSON REUTERS
·
Jul 31

Incannex Healthcare Unveils Promising Phase 2 Trial Results for IHL-42X, Paving Way for Potential Breakthrough in Sleep Apnea Treatment

Reuters
·
Jul 30

Incannex Healthcare Inc - No Serious Adverse Events Reported in Trial

THOMSON REUTERS
·
Jul 30

Incannex Reports Positive Topline Results From Reposa Phase 2 Trial of Ihl-42X

THOMSON REUTERS
·
Jul 30

Incannex Healthcare Inc. Appoints Dr. Charlene E. Gamaldo to Clinical Advisory Board for Obstructive Sleep Apnea Program

Reuters
·
Jul 25

BRIEF-Incannex Healthcare Inc Files For Common Stock Offering Of Up To $100 Million - SEC Filing

Reuters
·
Jul 25

Incannex Healthcare Expands "At-The-Market" Offering Capacity by $100 Million to Enhance Financial Flexibility

Reuters
·
Jul 25

Incannex Healthcare Inc Files for Common Stock Offering of up to $100 Mln - SEC Filing

THOMSON REUTERS
·
Jul 25

Press Release: Incannex Healthcare Expands Clinical Advisory Board to Support Obstructive Sleep Apnea Program with Appointment of Dr. Douglas B. Kirsch

Dow Jones
·
Jun 24

Incannex Healthcare Achieves Key Milestone with Phase 2 Trial Database Lock for First-in-Class OSA Drug, Top-Line Results Expected July 2025

Reuters
·
Jun 18

Incannex Healthcare and Mind Medicine Australia Launch Joint Venture for Psychedelic-Assisted Therapy Clinic in Melbourne

Reuters
·
Jun 17

Incannex Healthcare Inc. Initiates Transfer of Listing to Nasdaq Capital Market to Meet Compliance Requirements

Reuters
·
Jun 13

Incannex Healthcare Streamlines Capital Structure, Cancels Series A Warrants Ahead of Key Phase 2 Trial Milestone for IHL-42X in Obstructive Sleep Apnea

Reuters
·
Jun 12

Press Release: Incannex Healthcare Inc. Expands IHL-42X Clinical Advisory Board with Appointments of Four Industry and Academic Leaders to Advance Obstructive Sleep Apnea (OSA) Program

Dow Jones
·
Jun 03

Incannex Healthcare Inc. Advances to Phase 3 Clinical Trial for IHL-42X in Obstructive Sleep Apnea Treatment, Following FDA Authorization

Reuters
·
May 29

BRIEF-Incannex Healthcare Advances IHL-42X Reposa Trial To Phase 3 Following FDA Protocol Clearance

Reuters
·
May 29

Stonegate Capital Partners Updates Coverage on Incannex Healthcare, Highlights Cost Savings and Financial Improvements

Reuters
·
May 29

Incannex Healthcare Cancels Series A Warrants, Eliminates Potential Dilution of 347 Million Shares Ahead of Key Trial Results

Reuters
·
May 28